ONCAlert | 2017 San Antonio Breast Cancer Symposium

Novel Agents for Neoadjuvant TNBC Treatment

Anees B. Chagpar, MD
Published Online:11:02 AM, Wed March 29, 2017

Anees B. Chagpar, MD, associate professor of Surgery (Oncology), director of The Breast Center at Smilow Cancer Hospital at Yale-New Haven, Yale Cancer Center, discusses novel agents for neoadjuvant triple-negative breast cancer (TNBC) treatment.
Copyright © TargetedOnc 2017 Intellisphere, LLC. All Rights Reserved.